Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto L Epstein

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|June 17, 2024
Safety of non-replicative and oncolytic replication-selective HSV vectorsAlberto L Epstein, Samuel D Rabkin
Medecine Sciences : M/S|June 11, 2015
[Herpes simplex virus type 1 latency and reactivation: an update]Alejandro M Aranda, Alberto L Epstein
Cell|August 18, 2023
Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)Alberto L Epstein, Cornelia Haag-Molkenteller
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Herpes simplex virus type 1-derived recombinant and amplicon vectorsCornel Fraefel, Peggy Marconi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapyCornel Fraefel, Peggy Marconi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapyPeggy Marconi, Cornel Fraefel, Alberto L Epstein
Current Opinion in Drug Discovery & Development|March 6, 2010
HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseasesPeggy Marconi, Roberto Manservigi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectorsMatias E Melendez, Cornel Fraefel, Alberto L Epstein
Human Gene Therapy|July 30, 2003
Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomesCécile Zaupa, Valerie Revol-Guyot, Alberto L Epstein
Advances in Experimental Medicine and Biology|January 5, 2010
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|June 17, 2024
Safety of non-replicative and oncolytic replication-selective HSV vectorsAlberto L Epstein, Samuel D Rabkin
Medecine Sciences : M/S|June 11, 2015
[Herpes simplex virus type 1 latency and reactivation: an update]Alejandro M Aranda, Alberto L Epstein
Cell|August 18, 2023
Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)Alberto L Epstein, Cornelia Haag-Molkenteller
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Herpes simplex virus type 1-derived recombinant and amplicon vectorsCornel Fraefel, Peggy Marconi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapyCornel Fraefel, Peggy Marconi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2014
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapyPeggy Marconi, Cornel Fraefel, Alberto L Epstein
Current Opinion in Drug Discovery & Development|March 6, 2010
HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseasesPeggy Marconi, Roberto Manservigi, Alberto L Epstein
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2014
Herpes simplex virus type 1 (HSV-1)-derived amplicon vectorsMatias E Melendez, Cornel Fraefel, Alberto L Epstein
Human Gene Therapy|July 30, 2003
Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomesCécile Zaupa, Valerie Revol-Guyot, Alberto L Epstein
Advances in Experimental Medicine and Biology|January 5, 2010
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Alberto L Epstein, et al.
Pageof 6